• Questions? +1 (732) 747-1007
  • ir@americancryostem.com
  • Physicians
  • Licensing & Partners
  • SERVICES
    • HOW IT WORKS
    • COSMETIC CRYO-FAT
    • ADULT STEM CELLS
  • PRODUCTS
    • TISSUE HARVESTING SYSTEM
    • STEM CELL MEDIAS
    • STEM CELL LINES
  • OUR SCIENCE
  • INVESTORS
    • ABOUT US
    • STOCK INFORMATION
    • PRESS RELEASES
    • OUR LEADERSHIP
    • LICENSING PARTNERS
  • NEWS
  • CONTACT

ATGRAFT fat storage featured on FoxFiveNY News

October 17, 2014

American CryoStem physician Dr. Mark Warfel featured on FoxFiveNY news about offering our ATGRAFT fat storage service. 

About ATGRAFT fat storage service: 

Autologous fat transfer is an increasingly preferred procedure by patients looking for natural augmentation and correction procedures. Now, with the increased benefit of using your own stored adipose tissue as a natural filler for procedures offered by your physician, you may only need to have a single liposuction, improving your recovery time and reducing additional procedure costs.

Patients are enjoying the ability in having their stored adipose tissue available after the initial procedure for continued augmentations to gain the desired result in procedures such as: natural augmentation of the breast and buttocks or volume corrections in the hands, face and neck by using their own stored adipose tissue.

Watch the interview below:

https://www.youtube.com/watch?v=YSkpBrfXpBY

American CryoStem ATGRAFT Fat Storage System
Share

Related posts

January 6, 2023

American CryoStem Announces FDA Approval of IND to Commence Phase I Clinical Trial for Long COVID/Post-Acute Sequelae of SARS-CoV-2 (PASC)


Read more
December 22, 2022

American CryoStem Announces the Addition of Agustin Legido, MD, PhD, MBA to its Advisory Board


Read more
March 4, 2022

American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)


Read more

About American CryoStem Corporation

American CryoStem Corporation (OTC:CRYO), is a clinical-stage biotechnology company, global licensor and a pioneer in autologous (one’s own) cellular processing and therapies. The Company's centralized laboratory model and patented foundational “CryoStem Platform” is a best-in-class, end-to-end cellular therapy solution to treat injuries, disorders and chronic diseases through a single adipose-tissue (fat) harvest and ATCELLBank™ cryopreservation. We are dedicated to helping the world’s physicians, hospitals, and clinics improve clinical outcomes by developing and delivering effective leading-edge stem cell therapies that improve patient health and quality of life.

© 2021 American CryoStem Corporation | A Publicly Traded Company (CRYO)
  • Physicians
  • Licensing & Partners